Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Nono
REST API REST API
Mus musculus
Nono is differentially expressed in 258 experiments: 106 organism parts: liver, hippocampus, ... (104 more);, 14 disease states: normal, LPS-induced acute lung injury, ... (12 more);, 72 cell types 15 cell lines 32 compound treatments and 39 other conditions.
Synonyms 'P54NRB'
Orthologs NONO (Homo sapiens)   Q5ZIZ5_CHICK (Gallus gallus)   Q2KJ42_BOVIN (Bos taurus)   ENSCING00000004050 (Ciona intestinalis)   Nono (Rattus norvegicus)   nonA-l (Drosophila melanogaster)   nonA (Drosophila melanogaster)   nono (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term RNA splicing, DNA binding, protein binding, DNA repair, regulation of transcription, DNA-dependent, transcription, DNA-dependent, nucleic acid binding, nuclear matrix, identical protein binding, nucleus, DNA recombination, nucleotide binding, mRNA processing, response to DNA damage stimulus, RNA binding, paraspeckles
InterPro Term NOPS, RRM_dom
Search EB-eye ENSMUSG00000031311
Show more properties
Experimental Factors
Organism part

studied in E-TABM-1039, E-GEOD-1479, E-GEOD-20160, E-GEOD-2866, E-MEXP-1636, ... (52 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-21515, E-GEOD-19732, E-GEOD-1956, E-GEOD-10246, E-MEXP-2554, ... (7 experiments)

Factor Value U/D Experiments
N1E-115 wild_type
1
E-GEOD-1956
B117P
2
1
E-GEOD-2788
R1
1
E-GEOD-21515
MBA1
1
E-MEXP-2554
B140P
2
1
E-GEOD-2788
IP14D-101
1
E-GEOD-21515
9 more value(s).


Cell type

studied in E-GEOD-7069, E-GEOD-7764, E-GEOD-829, E-GEOD-4142, E-GEOD-272, ... (27 experiments)

Factor Value U/D Experiments
pachytene spermatocyte
2
E-GEOD-4193, E-TABM-412
hematopoietic stem cell
1
2
E-GEOD-7069, E-MEXP-1158, E-GEOD-20377
lacrimal gland
1
E-GEOD-10246
spleen
1
E-GEOD-10246
T effector cell
1
E-GEOD-1419
tubular somatic cell
1
E-GEOD-829
66 more value(s).


Disease state

studied in E-MEXP-1296, E-GEOD-6461, E-GEOD-19004, E-GEOD-21902, E-GEOD-2514, ... (9 experiments)

Factor Value U/D Experiments
normal
2
3
E-MEXP-1296, E-GEOD-2514, E-GEOD-6461, E-GEOD-21543, E-GEOD-21902 ... (5 experiments)
tumor
1
E-GEOD-21902
mouse model of Huntington's disease
1
E-GEOD-3583
mPIN (mouse prostatic intraepithelial neoplasia)
1
E-GEOD-21543
prostate carcinoma
1
E-MEXP-1296
synovial sarcoma
1
E-GEOD-6461
8 more value(s).


Compound treatment

studied in E-GEOD-21711, E-GEOD-19684, E-GEOD-21927, E-TABM-903, E-GEOD-6085, ... (22 experiments)

Factor Value U/D Experiments
lipopolysaccharide
2
E-TABM-310, E-GEOD-2411
cardiotoxin
2
E-GEOD-5304, E-MEXP-703
Penicillin G
1
E-TABM-903
T0901317
1
E-MEXP-3282
ethanol
1
E-MEXP-774
Tamoxifen
1
E-GEOD-19684
26 more value(s).


Agent

studied in E-GEOD-32706

Factor Value U/D Experiments
fenofibrate
1
1
E-GEOD-32706


Amount to core
studied in E-GEOD-18858

cell population
studied in E-GEOD-26086

Clinical info
studied in E-MEXP-1458

Clinical treatment
studied in E-GEOD-3075

Cohort
studied in E-GEOD-20524

Developmental stage
studied in E-GEOD-1026, E-GEOD-1479, E-GEOD-1867, E-GEOD-8191, E-GEOD-989, ... (36 experiments)

dose or concentration
studied in E-GEOD-18858

Generation
studied in E-GEOD-6527

Genotype
studied in E-GEOD-19684, E-GEOD-19004, E-GEOD-6526, E-MEXP-1649, E-TABM-285, ... (40 experiments)

Growth condition
studied in E-GEOD-1867, E-GEOD-4310, E-GEOD-1776

Histology
studied in E-GEOD-15904

in vivo treatment
studied in E-GEOD-18858

Individual
studied in E-GEOD-18858

Infection
studied in E-GEOD-4324, E-MEXP-1717, E-GEOD-20302, E-MEXP-1942

infection duration (days)
studied in E-GEOD-20524

infection status
studied in E-GEOD-20524

Light
studied in E-TABM-285

Media
studied in E-MEXP-718

Observation
studied in E-GEOD-5296

Organism
studied in E-MEXP-667

Phenotype
studied in E-GEOD-272

Protocol type
studied in E-GEOD-12293, E-GEOD-21389, E-GEOD-2917

Replicate
studied in E-GEOD-17112

Rna integrity number
studied in E-GEOD-18858

RNAi
studied in E-MEXP-1342

Route of exposure
studied in E-GEOD-18858

Sampling time point
studied in E-GEOD-4356

Sex
studied in E-GEOD-3463, E-MEXP-1711, E-GEOD-21048

Stimulus or stress
studied in E-GEOD-15894, E-GEOD-15901

Strain or line
studied in E-GEOD-17936, E-GEOD-21927, E-GEOD-2031, E-GEOD-16994, E-GEOD-21515, ... (9 experiments)

Transfect
studied in E-GEOD-6487

Treatment
studied in E-MTAB-76, E-GEOD-21902, E-GEOD-18344, E-GEOD-22009, E-GEOD-21841, ... (10 experiments)

Treatment repeat
studied in E-GEOD-18858

Treatment time
studied in E-GEOD-18858

Units of amount
studied in E-GEOD-18858

Units of duration
studied in E-GEOD-18858

units of treatment repeat
studied in E-GEOD-18858

vehicle for chemical
studied in E-GEOD-18858

Processing time: 0.195 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM